Elekta sues ZAP Surgical Systems, claiming patent infringement

Huge Two-Day Clean Sweep Auction July 24-25th. Click Here to Bid!

advertisement
Posição atual:
>
> This Story


Início de uma sessão ou Registo to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Rad Oncology Homepage

Research shows how hurricanes hinder radiotherapy outcomes Treatment transfers and eliminating out-of-network insurance charges could help

Elekta to distribute C-RAD SIGRT technology in North America and Mexico Advances stereotactic radiosurgery and stereotactic body radiotherapy

CMS proposes alternative payment model for radiation oncology Uses prospective, episode-based payments; ensures value-based care

FDA gives RaySearch green light for RayStation 8B platform First treatment planning system to offer machine learning applications

MedAustron to add health IT to proton and carbon ion treatment facilities Orders more than $13 million worth of RaySearch systems

'Nudge' in EHRs cuts imaging in half for palliative radiotherapy, says study Reduces duration of radiotherapy sessions

Mayo Clinic Florida campus to get $233 million proton facility The 140,000-square-foot facility will house a two-gantry proton system

Demand on the rise for MR-guided radiotherapy, says new report Compound annual growth rate of 20 percent through 2028

New proton therapy center planned in Russia Investment calls for 7.5 billion rubles to bring greater cancer care to patients

NYC proton facility opens for business $300 million dollar, 140,000 square-foot facility was ten years in the making

Elekta is suing ZAP Surgical
Systems over what it claims is
patent infringement of its rotatable
radiation treatment system

Elekta sues ZAP Surgical Systems, claiming patent infringement

por John R. Fischer , Staff Reporter
Radiotherapy provider Elekta is taking ZAP Surgical Systems to court over allegations of patent infringement, regarding the design of a radiosurgery platform.

The California-based enterprise filed the suit, titled Elekta Limited and Elekta Inc. v. ZAP Surgical Systems, Inc., this month in the United States District Court for the Northern District of California, asserting that the manufacturing, importation, advertising, sale and use of the ZAP-X Gyroscopic Radiosurgery Platforms violates a patent for a rotatable treatment system designed by Elekta.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



"Zap Surgical is acting quickly and will defend itself aggressively," said John Adler in a statement to HCB News. "We have engaged with legal counsel and already our team has identified several promising non-infringement and invalidity positions that we are working to develop further."

Elekta Limited is seeking monetary damages with a threefold enhancement for willful infringement, and an injunction to prevent the importing, manufacturing, sale and use of the product in the U.S.

"Elekta is a recognized innovator in radiation-based treatment technologies," said Jonas Bolander, general counsel and executive vice president for Elekta, in a statement. "We invest heavily in the research and development of new and better therapies for patients, and we value and vigorously protect the intellectual property rights that result from such investment. As demonstrated in the past, Elekta will not accept any violation of its intellectual property rights."

Its suit follows the adoption of ZAP Surgical Systems’ radiosurgery platform, which gained FDA clearance in 2017, by Barrow Brain and Spine in Phoenix, Arizona to deliver stereotactic radiotherapy to treat patients with brain tumors. In addition, clinical trials are expected to begin in June in Beijing.

Equipped with self-shielding technology, the solution is designed as an alternative to invasive surgery that delivers high-dose radiation to brain tumors precisely, while protecting normal brain tissue and other organs, such as the eyes. It requires no cement radiation vault to protect operators when in use, saving providers an estimated one to two million dollars.

“It’s like a shaper knife,” Dr. John Adler, founder and CEO of ZAP Surgical Systems and a professor of Neurosurgery at Stanford University, told HCB News at the time of its adoption at Barrow Brain and Spine, noting that the ZAP-X platform is more precise, from more directions, than existing SRS technology. The ZAP-X is also safer because it lets operators record the radiation as it is being administered, he added.

The patent, No. 7,295,648, is one of many granted worldwide and claims priority from GB Patent Application Nos. 0324676.6 and 0325698.9.

Elekta did not respond for comment.

Rad Oncology Homepage


You Must Be Logged In To Post A Comment